Pharmacology, Toxicology and Pharmaceutical Science
Antifungal
100%
Amphotericin B
74%
Aspergillus
74%
Isavuconazole
55%
Pyrrole Derivative
53%
Posaconazole
53%
Infection
44%
Itraconazole
42%
Frontotemporal Dementia
37%
Pyrrole
37%
Epidemiology
37%
Mucorales
37%
Terbinafine
37%
Trichophyton
37%
Dermatophyte
37%
DNA
35%
Voriconazole
35%
Amyotrophic Lateral Sclerosis
29%
Echinocandin
18%
Respiratory Tract
18%
Motor Neuron Disease
14%
Hereditary Motor Sensory Neuropathy
14%
Human
14%
Diseases
9%
Incidence
9%
Mucormycosis
9%
Rhizopus
9%
Mucor
9%
Mycosis
9%
Cunninghamella
9%
Aspergillosis
9%
Aspergillus fumigatus
9%
Antifungal Therapy
9%
Immunocompromised Patient
9%
Environmental Exposure
9%
Glycine
9%
Survival Rate
9%
Aspergillus terreus
9%
Fungus
9%
Micafungin
9%
Polyene
9%
Multiple Sclerosis
7%
Dysphagia
7%
Bulbar Paralysis
7%
Weakness
7%
Paralysis
7%
Dysarthria
7%
Dyspnea
7%
Primary Lateral Sclerosis
7%
Cognitive Defect
7%
Immunology and Microbiology
Antifungal Susceptibility
100%
Species
98%
Sample
83%
Aspergillus
74%
Species Distribution
64%
Minimum Inhibitory Concentration
59%
Species Identification
51%
Trichophyton
37%
Dermatophyte
37%
Genus
37%
Terbinafine
37%
Mucorales
37%
DNA Sequence
35%
Broth Dilution
35%
Gene
18%
Time
18%
Wild Type
18%
Human
14%
Rhizopus
9%
Aspergillus fumigatus
9%
New Species
9%
Promoter Region
9%
Mucor
9%
Lower Respiratory Tract
9%
Fungus
9%
Aspergillus terreus
9%
Cunninghamella
9%
Awareness
9%
Immunocompromised Patient
9%
Lung
9%
Upper Respiratory Tract
9%
Incidence
9%
Mutation
9%
Survival Rate
9%
Trichophyton Rubrum
7%
Trichophyton Mentagrophytes
7%
Trichophyton Interdigitale
7%
Nail
7%
Hair
7%
Data Base
7%
Skin
7%
Contrast
7%
Medicine and Dentistry
Dermatofibrosarcoma Protuberans
39%
Diagnosis
37%
Small-Cell Carcinoma
37%
Ovary
37%
Female
37%
Frontotemporal Lobar Degeneration
37%
Gene
37%
Hematopathology
37%
Laboratory
37%
Neoplasm
29%
Amyotrophic Lateral Sclerosis
29%
Next Generation Sequencing
29%
Patient
22%
Recurrent Disease
22%
Analysis
22%
Fluorescence in Situ Hybridization
22%
Family
18%
Patient Support Group
16%
Male
14%
Heterozygosity
14%
Immunoreactivity
14%
Inhibin
14%
Morphology
14%
DeJerine-Sottas Disease
14%
Penetrance
14%
Breast
14%
Reimbursement
14%
Development
14%
Hematologic Malignancy
14%
Patient Care
11%
Sarcoma
9%
Rare Tumor
8%
Cyst
7%
Surgery
7%
Differentiation
7%
Karyotype 46,XX
7%
Transplantation
7%
Deterioration
7%
Cells
7%
Element
7%
Epithelial Membrane Antigen
7%
Carboplatin
7%
Paclitaxel
7%
Clinical Management
7%
Chromosome Analysis
7%
Paralysis
7%
Nonsense Mutation
7%
Bulbar Palsy
7%
Cognition
7%
Cognitive Defect
7%